FDA, EMEA, EC extend regulatory collaboration efforts

被引：0

|

作者：

机构：

来源：

Pharm. Technol. | 2007年 / 8卷 / 22期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

相关论文

共 50 条

[21] SYMPOSIUM: EFFORTS TO EXTEND EFFECTIVE COVERAGE IN ASIA
O'Donnell, Owen
Jones, Andrew M.
HEALTH ECONOMICS, 2016, 25 (06) : 647 - 649
[22] Celera and Merck extend osteoporosis collaboration
不详
PHARMACOGENOMICS, 2002, 3 (01) : 4 - 4
[23] Karo Bio and BMS extend their collaboration
不详
DIABETES OBESITY & METABOLISM, 2000, 2 (06): : 391 - 391
[24] Sandvik and Pathtrace extend working collaboration
不详
AIRCRAFT ENGINEERING AND AEROSPACE TECHNOLOGY, 2002, 74 (02): : 198 - 198
[25] CGN and Kazatomprom extend fuel collaboration
Kidd, Steve
NUCLEAR ENGINEERING INTERNATIONAL, 2015, 60 (728): : 11 - 11
[26] Should we modify hemoglobin targets in CKD patients?: FDA and EMEA statements
de Francisco, A. L. Martin
Aljama, P.
Arias, M.
Gorriz, J. L.
Martinez Castelao, A.
Portoles, J.
NEFROLOGIA, 2007, 27 (04): : 399 - 404
[27] EC COLLABORATION - CALL FOR PROPOSALS
WILLIS, D
PHYSICS WORLD, 1991, 4 (05) : 16 - 16
[28] An EC regulatory push
不详
OIL & GAS JOURNAL, 2012, 110 (02) : 26 - 26
[29] Assessing the Performance of the EMEA’s Centralized Procedure: A Comparative Analysis with the US FDA
Laura B. Faden
Kenneth I. Kaitin
Drug information journal : DIJ / Drug Information Association, 2008, 42 (1): : 45 - 56
[30] Patient reported outcomes in labeling for oncology products: Review of FDA and EMEA labels
Caron, M.
Emery, M. P.
Marquis, P.
Piault, E.
VALUE IN HEALTH, 2007, 10 (03) : A141 - A141

← 1 2 3 4 5 →